Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 635Glioblastoma 566Glioma 405Neuroblastoma 174Neoplasms 123Astrocytoma 106Central Nervous System Neoplasms 103Medulloblastoma 87Breast Neoplasms 86Meningioma 82Carcinoma, Non-Small-Cell Lung 78Melanoma 77Lung Neoplasms 69Sarcoma 66Ependymoma 64Neurofibromatosis 1 63Recurrence 50Oligodendroglioma 48Neoplasm Metastasis 48Osteosarcoma 47Meningeal Carcinomatosis 46Rhabdomyosarcoma 45Diffuse Intrinsic Pontine Glioma 44Pheochromocytoma 43Rhabdoid Tumor 41Paraganglioma 41Gliosarcoma 40Sarcoma, Ewing 39Pancreatic Neoplasms 39Colorectal Neoplasms 33

Interventions

Lovastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dyslexia × CNS × 1 year × Clear all
NCT00624234 2025-07-08

Neurobiology and Treatment of Reading Disability in NF-1

Vanderbilt University

Phase NA Completed
184 enrolled 10 charts
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

NCT02964884 2025-06-24

Interventions for Reading Disabilities in NF1

Vanderbilt University

Phase 2 Active not recruiting
120 enrolled
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡